Prevail Therapeutics Provides Program Update on PR001 in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease

September 10, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search